USPTO Patents Application 09993647

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

In re Application of : Bernd Riedl et al.

Serial No.: 09/993,647 Group Art Unit: 1624

Filed: November 27, 2001 Examiner: Deepak R. RAO

For: co- Carboxaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
INFORMATION DISCLOSURE STATEMENT UNDER 37 CFR §§ 1.56, 1.97 and 1.98

Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450

Sir:

This information disclosure statement is made in accordance with 37 C.F.R. §§1 .56, 1 .97
and 1.98 as follows:

Timing and Fees

XI Under 37 C.F.R. § 1.97(b), no fee or statement is required for filing this information
disclosure statement is filed:

I I within three months of the filing date of a national application other than a CPA
under § 1.53(d);

I I within three months of the actual filing date of the national phase of a PCT
application; OR

XI before the mailing of a first substantive office action (including after filing of an
RCE).

I I Under 37 C.F.R. § 1 .97(c), this information disclosure statement is filed after the periods
specified in 37 C.F.R. § 1.97(b), but before the mailing date of:

a final rejection under 37 C.F.R. 1.113;

termination of prosecution, e.g. Ex Parte Quayle, M.P.E.P § 609(B)(2); OR
a notice of allowance under 37 C.F.R. § 1.311; and

1

BAYER-0018-A

is accompanied by:

I I the statement as specified in 37 C.F.R. § 1.97(e) set out below;

□ a check covering the fee of $180.00 under 37 C.F.R. § 1.17(p); or

I I payment by credit card via EFS covering the fee of $180.00 under 37
C.F.R. § 1.17(p);or

I I Under 37 C.F.R. § 1 .97(d), this information disclosure statement is filed after the mailing
date of the following actions which have not been withdrawn:

□ a final action under 37 C.F.R. § 1.1 13;

I I termination of prosecution, e.g. Ex Parte Quayle, M.P.E.P § 609(B)(2);

I I OR a notice of allowance under 37 C.F.R. § 1.31 1;

AND is filed on or before payment of the issue fee; AND is accompanied by:

the statement as specified in 37 C.F.R. § 1 .97(e) as set forth below, and the fee of
$180.00 under 37 C.F.R. § 1.17(p).

Statements Under 37 C.F.R. 1.97(e)

Each item of information contained in this information disclosure
statement was cited in a communication from a foreign patent office in a
counterpart foreign application having a mailing date not more than three
months prior to the filing date of this information disclosure statement; or

No item of information contained in this information disclosure statement
was cited in a communication from a foreign patent office in a counterpart
foreign application, and to the knowledge of the undersigned attorney
after making reasonable inquiry, no item of information contained in this
information disclosure statement was known to any individual designated
in 37 C.F.R. § 1.56(c) more than three months prior to the filing date of
the information disclosure statement.

I I Copies of materials listed but not attached were cited in benefit (35 U.S .C. § 120)

ancestor application Serial No. , on Form 892 by the Examiner

and/or Form 1449 by the applicant; see 37 C.F.R. § 1.98(d).

Copies of materials listed but not attached were cited in an international search
report dated .

2

BAYER-0018-A

□

□

Cited Materials

□

□ Not required by 37 CFR §1.98.

XI Copies of the materials listed are attached (except for the U.S. references).

Non-English Language References

I I An English-language search report or equivalent paper from a foreign patent
office is provided indicating the relevance of the cited reference(s).

I I A foreign-language search report from a foreign patent office is provided, and
pertinent parts are translated substantively below:

X = document of particular relevance when it is taken alone
Y = document of particular relevance when it is combined with another such
document

A = document defining the general state of the art
O = non-written disclosure
P = intercalated document

T = document cited to understand the theory or principle underlying the
invention

E = patent document which has the benefit of a date earlier than the filing date

and which was published only on or after this filing date
D = cited in the application
L = cited for another reason
& = publication of member of same patent family

I I Translation of other relevant information on foreign search report

[insert necessary translation here]

Other Information

Payment of Fees Due (If Any) :

□ A check for $ covering the fee identified above is attached.

XI Payment by credit card via EFS for $covering the fee identified above.

I I Please charge to Deposit Account No. 13-3402 $ for the fee identified above.

3

BAYER-0018-A

XI The Commissioner is hereby authorized to charge or credit any overpayment to Deposit
Account #13-3402, two copies of this paper are attached for this purpose.

MILLEN, WHITE, ZELANO

& BRANIGAN, P.C.
Arlington Courthouse Plaza 1
2200 Clarendon Blvd. Suite 1400
Arlington, Virginia 22201
Telephone: (703) 243-6333
Facsimile: (703) 243-6410

Attorney Docket No. : BAYER-00 1 8- A

Date: June 1, 2010

Respectfully submitted,

/Richard J. Traverso/

Richard J. Traverso
Attorney/Agent for Applicants

4

BAYER-00 18- A